Hormone replacement therapy for all? Arguments should be based on ratio of benefits to risks.
作者信息
Bewley S
出版信息
BMJ. 1996 Nov 9;313(7066):1205-6. doi: 10.1136/bmj.313.7066.1205d.
Abstract
摘要
相似文献
1
Hormone replacement therapy for all? Arguments should be based on ratio of benefits to risks.全民激素替代疗法？争论应基于利弊比。
BMJ. 1996 Nov 9;313(7066):1205-6. doi: 10.1136/bmj.313.7066.1205d.
2
Menopause: refining benefits and risks of hormone replacement therapy.更年期：优化激素替代疗法的益处与风险
Curr Opin Obstet Gynecol. 1995 Jun;7(3):214-9.
3
Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis.长期雌激素替代疗法的相对风险与益处：一项决策分析。
Obstet Gynecol. 1994 Feb;83(2):161-6.
4
Hormone replacement therapy--risks and benefits.激素替代疗法——风险与益处
S Afr Med J. 1997 Nov;87(11):1500-2.
5
[Risks and benefits of postmenopausal hormone replacement therapy].绝经后激素替代疗法的风险与益处
Orv Hetil. 1998 Nov 1;139(44):2639-42.
6
Postmenopausal hormone therapy: cardiovascular risks.绝经后激素治疗：心血管风险
Prescrire Int. 2003 Apr;12(64):65-9.
7
Benefits and risks of hormone/estrogen replacement.
Nurs Clin North Am. 1996 Dec;31(4):815-25.
8
Hormone replacement therapy at the menopause. The risks and benefits.
Aust Fam Physician. 1990 Jan;19(1):73-5, 78-81, 84-5.
9
Risks and benefits of replacement estrogen.雌激素替代疗法的风险与益处。
Annu Rev Med. 1992;43:239-51. doi: 10.1146/annurev.me.43.020192.001323.
10
Update: the latest on hormone replacement therapy.最新消息：激素替代疗法的最新情况。
J Am Osteopath Assoc. 2000 Oct;100(10 Su Pt 1):S2-5.
引用本文的文献
1
Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator.左美洛昔芬：单次及多次服用新型选择性雌激素受体调节剂后在健康绝经后女性中的安全性、药效学和药代动力学
Br J Clin Pharmacol. 2002 Mar;53(3):284-95. doi: 10.1046/j.0306-5251.2001.01181.x.
本文引用的文献
1
Hormone replacement therapy for all? Universal prescription is desirable.全民激素替代疗法？普遍开出处方是可取的。
BMJ. 1996 Aug 10;313(7053):350-1. doi: 10.1136/bmj.313.7053.350.
Zotero 插件